27 June 2017

Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry

Posted in Scientific News, Research News, Pulmonary Function Tests, Clinical CPET

indirect calorimetry

A study published on the Respiratory Medicine Journal investigates the need for additional research on smokers with respiratory symptoms (dyspnoea, cough, or sputum production) and normal spirometry.

The purpose of this study was to evaulate whether symptomatic smokers with borderline spirometry (post-bronchodilator FEV1/FVC ratio between 5th to 20th percentile of predicted values) have pulmonary function abnormalities at rest and ventilatory constraints during exercise.

48 subjects (aged 60 ± 8 years, mean ± SD, 73% males, 16 healthy, and 17 symptomatic smokers) underwent cardiopulmonary exercise testing (CPET), body plethysmography, nitrogen singlebreath washout test (N2SBW), lung diffusion for carbon monoxide (DLCO), and forced oscillation technique (FOT).

In presence of respiratory symptoms not fully explained by spirometry, a careful diagnostic approach requires second line tests. Indeed, without a diagnosis it is impossible to prescribe the right therapy, schedule a correct follow-up, and postulate a prognosis. In our study CPET and second line pulmonary function tests revealed an obstructive pattern in symptomatic smokers undetected at spirometry.Whether the natural history of these patients is similar to COPD, and they deserve a similar therapeutic approach is worth investigating. Without a clear demonstration of long-term benefit of bronchodilators in patients with normal spirometry and an obstructive pattern at second-level pulmonary function tests, a strict follow-up appears the current most reasonable approach.

The article details are the following:

- Title: "Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry"
- Authors: Di Marco F, Terraneo S, Job S, Rinaldo RF, Sferrazza Papa GF, Roggi MA, Santus P, Centanni S
- Published in
: Respir Med. 2017 Jun;127:7-13

The study can be purchased at the following link: click here


Founded in 1980, COSMED is a privately owned company manufacturing Cardio Pulmonary and Metabolic Diagnostic Equipment. COSMED products include a full range of Spirometers, Pulmonary Function, Body Composition, Nutritional Assessment and Cardio Pulmonary Exercise systems, including Electrocardiographs, Ergometers and Assessment Software. COSMED solutions are aimed for either professional or medical use for many different applications like: Hospital, Clinics, Primary Care, University & Education in Human Physiology, Clinical Nutrition, Commercial Weight Management, Human Performance Centers, Sport Institutions and Health Club Industry. COSMED Headquarters are located in the province of Rome, Italy. COSMED has subsidiaries in the USA, China and Germany, and distributes its products internationally through a constantly growing distributor network covering more than 70 countries.